378 related articles for article (PubMed ID: 12414423)
41. Clinical Effectiveness of Monocanalicular Silicone Intubation for Congenital Nasolacrimal Duct Obstruction Under Nasal Endoscopic Visualization of the Terminal End of the Obstructed Nasolacrimal Duct.
Han JY; Lee H; Chang M; Park M; Lee JS; Baek S
J Craniofac Surg; 2015 Jun; 26(4):1328-31. PubMed ID: 26080187
[TBL] [Abstract][Full Text] [Related]
42. Results of probing for congenital nasolacrimal duct obstruction in children older than 13 months of age.
Maheshwari R
Indian J Ophthalmol; 2005 Mar; 53(1):49-51. PubMed ID: 15829747
[TBL] [Abstract][Full Text] [Related]
43. Success Rate of Probing for Congenital Nasolacrimal Duct Obstruction in Children.
Valcheva KP; Murgova SV; Krivoshiiska EK
Folia Med (Plovdiv); 2019 Mar; 61(1):97-103. PubMed ID: 31237856
[TBL] [Abstract][Full Text] [Related]
44. The Use of Anterograde Percutaneous Transluminal Coronary Angioplasty Balloons in Congenital Nasolacrimal Duct Obstruction: A Cost-Effective Alternative to the Traditional Dacryoplasty Balloons.
Bothra N; Gupta N; Nowak R; Ali MJ
Ophthalmic Plast Reconstr Surg; 2020; 36(3):302-304. PubMed ID: 31809489
[TBL] [Abstract][Full Text] [Related]
45. Success Rates of Conventional Versus Endoscope-Assisted Probing for Congenital Nasolacrimal Duct Obstruction in Children 12 Years and Younger.
Galindo-Ferreiro A; Akaishi P; Cruz A; Khandekar R; Dossari S; Dufaileej M; Galvez-Ruiz A; Schellini S
J Pediatr Ophthalmol Strabismus; 2016 Sep; 53(5):292-9. PubMed ID: 27383144
[TBL] [Abstract][Full Text] [Related]
46. Balloon catheter dilatation for treatment of congenital nasolacrimal duct obstruction.
Kushner BJ
Am J Ophthalmol; 1996 Oct; 122(4):598-9. PubMed ID: 8862069
[No Abstract] [Full Text] [Related]
47. A Case Series of Dacryoendoscopy in Childhood: A Diagnostic and Therapeutic Alternative for Complex Congenital Nasolacrimal Duct Obstruction Even in the First Year of Life.
Heichel J; Struck HG; Fiorentzis M; Hammer T; Bredehorn-Mayr T
Adv Ther; 2017 May; 34(5):1221-1232. PubMed ID: 28341931
[TBL] [Abstract][Full Text] [Related]
48. Factors Associated With Nasolacrimal Duct Probing Failure Among Children in the Intelligent Research in Sight Registry.
Oke I; Elze T; Miller JW; Lorch AC; Hunter DG; Elliott AT;
JAMA Ophthalmol; 2023 Apr; 141(4):342-348. PubMed ID: 36862386
[TBL] [Abstract][Full Text] [Related]
49. Success rates of probing for congenital nasolacrimal duct obstruction at various ages.
Świerczyńska M; Tobiczyk E; Rodak P; Barchanowska D; Filipek E
BMC Ophthalmol; 2020 Oct; 20(1):403. PubMed ID: 33032542
[TBL] [Abstract][Full Text] [Related]
50. Congenital Nasolacrimal Duct Obstruction: Comparison of Two Different Treatment Algorithms.
Napier ML; Armstrong DJ; McLoone SF; McLoone EM
J Pediatr Ophthalmol Strabismus; 2016 Sep; 53(5):285-91. PubMed ID: 27486727
[TBL] [Abstract][Full Text] [Related]
51. Factors affecting the success of nasolacrimal duct probing for congenital nasolacrimal duct obstruction.
Mannor GE; Rose GE; Frimpong-Ansah K; Ezra E
Am J Ophthalmol; 1999 May; 127(5):616-7. PubMed ID: 10334364
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of treatment modalities and prognostic factors in children with congenital nasolacrimal duct obstruction.
Al-Faky YH; Al-Sobaie N; Mousa A; Al-Odan H; Al-Huthail R; Osman E; Al-Mosallam AR
J AAPOS; 2012 Feb; 16(1):53-7. PubMed ID: 22370666
[TBL] [Abstract][Full Text] [Related]
53. Outcome of Primary Probing for Simple Membraneous Congenital Nasolacrimal Duct Obstruction in Children Older Than 4 Years.
Reynolds M; Lueder G
J Pediatr Ophthalmol Strabismus; 2020 Jan; 57(1):44-47. PubMed ID: 31972040
[TBL] [Abstract][Full Text] [Related]
54. The Role of Inferior Turbinate Fracture in the Management of Congenital Nasolacrimal Duct Obstruction.
Rajabi MT; Inanloo B; Salabati M; Rafizadeh M; Tabatabaie SZ; Bayat R; Mahmoudzadeh R
Ophthalmic Plast Reconstr Surg; 2019; 35(3):269-271. PubMed ID: 30234839
[TBL] [Abstract][Full Text] [Related]
55. Surgical management of congenital nasolacrimal duct obstruction; one procedure for all versus all procedures for one.
Kashkouli MB; Karimi N; Khademi B
Curr Opin Ophthalmol; 2019 Sep; 30(5):364-371. PubMed ID: 31219833
[TBL] [Abstract][Full Text] [Related]
56. Dilation probing as primary treatment for congenital nasolacrimal duct obstruction.
Clark RA
J AAPOS; 2002 Dec; 6(6):364-7. PubMed ID: 12506277
[TBL] [Abstract][Full Text] [Related]
57. Endoscopically assisted balloon dacryoplasty treatment of incomplete nasolacrimal duct obstruction.
Couch SM; White WL
Ophthalmology; 2004 Mar; 111(3):585-9. PubMed ID: 15019340
[TBL] [Abstract][Full Text] [Related]
58. [Balloon dacryocystoplasty in the treatment of congenital nasolacrimal duct obstruction after previous unsuccessful surgery].
Yu G; Hu M; Wu Q; Cao WH; Fan YW; Lin Q; Liu W
Zhonghua Yan Ke Za Zhi; 2011 Aug; 47(8):698-702. PubMed ID: 22169608
[TBL] [Abstract][Full Text] [Related]
59. Effect of age on primary balloon dacryocystoplasty and probing success in congenital nasolacrimal duct obstruction.
Dericioğlu V; Sevik MO; Saçu SS; Eraslan M; Çerman E
Int Ophthalmol; 2022 Nov; 42(11):3547-3554. PubMed ID: 35598226
[TBL] [Abstract][Full Text] [Related]
60. The prevalence of amblyogenic factors in children with persistent congenital nasolacrimal duct obstruction.
Eshraghi B; Akbari MR; Fard MA; Shahsanaei A; Assari R; Mirmohammadsadeghi A
Graefes Arch Clin Exp Ophthalmol; 2014 Nov; 252(11):1847-52. PubMed ID: 24777709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
